- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05378568
Implementation and Evaluation of the Selection Scheme of Peripheral Venous Infusion Devices for Hospitalized Children
February 20, 2023 updated by: Children's Hospital of Fudan University
Implementation and Evaluation of the Selection Scheme of Peripheral Venous Infusion Devices for Hospitalized Children: a Stepped Wedge Cluster Randomized Trial
This study is a stepped wedge cluster randomized trial design.
The object is to evaluate the influence on patient outcomes, medical staff's evidence-based practice behavior and hospital context after implementation of the selection scheme of venous access devices comes from" Evidence-based guidelines for clinical practice of intravenous infusion therapy in children".
This study sought to compare the appropriateness of peripheral venous access device selection, to compare the incidence of infiltration and extravasation and the cost of venous infusion consumables before and after the implementation of the scheme.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study aimed to improve the standardization and suitability of device use and reduce complications associated with intravenous fluids by implementing best practice evidence for intravenous fluid device selection in children.
In 2021, the Chinese Journal of Evidence-Based Pediatrics released the " Evidence-based guidelines for clinical practice of intravenous infusion therapy in children".
The researchers used the evidence in this guideline as a standard to understand the current status of clinical intravenous infusion device selection and the gap between the current situation and the evidence.
The evidence tailor, baseline review, develop implementation plan, conduct implementation research.
A stepped wedge cluster randomized trial divided into 5 steps, 10 clusters(units), and the step size was one month.
Each included ward of a tertiary first-class pediatric hospital was regarded as a group, and each step was included into randomized two groups, and the observation was maintained for one month until all units were included in the intervention in the fifth month, with a total of 6 research periods.
Given the practicality of the study design, limited additional inclusion and exclusion criteria will be added.
Study Type
Interventional
Enrollment (Actual)
4652
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 201102
- Children's Hospital of Fudan University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
4 weeks to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria for nurses:
- Nurses have been working in the siting more than 1 year
- Nurses who can independently perform nursing operations (complete the contents related to intravenous infusion in the standardized training of hospital and pass the examination)
Inclusion Criteria for patients:
- Patients receiving intravenous infusion
- Hospitalized patients aged 28 days to 18 years
Exclusion Criteria for nurses:
- Nurses who has not obtained the practicing qualification certificate
- Nurses refused to participate in the study
Exclusion Criteria for patients:
- The indwelling time is less than 24h
- Patients who were put into intravenous catheter at admission and did not receive new catheter during hospitalization
- Patients with only one stat(st) order for intravenous infusion during hospitalization
- Patients refused to participate in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: the selection scheme of peripheral venous access devices
To implement the selection scheme of peripheral venous access devices, based on the Clinical Practice Guideline on Infusion Therapy in Children.
Then observe the appropriateness of peripheral venous access devices selection.
|
Based on the "Facilitator Toolkit" of the promoting action on research implementation in health services integrated framework(i-PARIHS), the implementation plan of peripheral intravenous infusion device selection in hospitalized children was formulated and applied, so as to change the practice behavior of nurses in the intervention group.
The specific process mainly includes: tailoring evidence; baseline review; situational analysis; promotion and implementation strategy like lectures, group discussions, operation demonstrations, and scenario simulations.
|
|
Active Comparator: the existing nursing routine
Follow the existing nursing routine of intravenous infusion and the selection of peripheral venous access devices.
|
To choose infusion device according to nurse's working experience.
First, nurse placed a peripheral intravenous catheter.
The patients and family decide whether to place the central intravenous infusion device according to the recommendation of the medical staff.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Error rate in peripheral intravenous infusion device selection
Time Frame: 6 months
|
The selection is made according to the recommendation of the guidelines.
Those who conform to the recommendation are correct, those who do not conform are wrong.
Calculation method: the error rate = (the number of cases with wrong peripheral intravenous infusion device selection)/(the total number of cases using peripheral intravenous infusion device)* 100%.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The knowledge level of nurses' intravenous infusion device selection
Time Frame: 6 months
|
The questionnaire has a total of 50 questions, 24 choice questions, 12 judgment questions, and 14 fill-in-the-blank questions, each with 2 points, and the total score is 100 points.
Before and after the implementation of the program, the evaluation will be conducted, a score of less than 60 is considered a failure, and a score of more than 80 is considered excellent.
|
6 months
|
|
Compliance of evidence-based practice behavior of nurses
Time Frame: 6 months
|
compliance of each review indicator = (the number of correct implementation of this indicator by nurses)/(the total number of reviews of this indicator) *100%
|
6 months
|
|
Incidence of infiltration and/or extravasation
Time Frame: 6 months
|
The bedside nurses document the number of incidents of peripheral venous infiltration and extravasation using "Pediatric Peripheral Venous Infiltration Scale".
The incidence of infiltration and/or extravasation = (case numbers of infiltration and/or extravasation)/(Catheter Days per Month)×1000‰.
|
6 months
|
|
The cost of intravenous infusion consumables
Time Frame: 6 months
|
including intravenous infusion devices (including the total number of catheters consumed by successful catheter placement and failed puncture), dress, central venous maintenance kits, infusion connectors, and tees.
|
6 months
|
|
Implementation process evaluation based on "Reach*Efficacy(RE)-Adoption, Implementation, and Maintenance(AIM)" framework
Time Frame: 6 months
|
including Reach, Efficacy, Adoption, Implementation, and Maintenance.
Reach refers to the participation rate of training courses; Efficacy refers to the change of knowledge level and compliance of evidence-based practice behavior of nurses in the intervention group; Adoption refers to the proportion of evidence actually adopted by nurses in the intervention group and the changes of context; Implementation refers to the completion rate of each training plan in the implementation strategy;Maintenance refers to evaluating the maintenance of the selection scheme.
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Ying Gu, doctor, Children's Hospital of Fudan University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 30, 2022
Primary Completion (Actual)
October 30, 2022
Study Completion (Actual)
October 30, 2022
Study Registration Dates
First Submitted
February 23, 2022
First Submitted That Met QC Criteria
May 16, 2022
First Posted (Actual)
May 18, 2022
Study Record Updates
Last Update Posted (Estimate)
February 22, 2023
Last Update Submitted That Met QC Criteria
February 20, 2023
Last Verified
February 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- FNF202112
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vascular Access Devices
-
Hospital Arnau de VilanovaCompletedVascular Access Complication | Nurse | Vascular Access Devices | NursesSpain
-
William Beaumont HospitalsCompletedVascular Access DevicesUnited States
-
Hospital de Clinicas de Porto AlegreCompletedVascular Access DevicesBrazil
-
Boehringer IngelheimCompletedVascular Access Devices | Catheter ObstructionRussian Federation
-
Centre hospitalier de l'Université de Montréal...CompletedCentral Venous Catheter | Vascular Access DevicesCanada
-
Golestan University of Medical sciencesCompletedVascular Access DevicesIran, Islamic Republic of
-
Ankara City Hospital BilkentCompletedMonitoring | Central Venous Catheterization | Pediatric Patients | Vascular Access DevicesTurkey (Türkiye)
-
University of AarhusUnknownUltrasonography | Pediatrics | Vascular Access DevicesDenmark
-
Children's Mercy Hospital Kansas CityNot yet recruitingEnteral Nutrition | Tube Feeding | Clogged Enteral Access Devices | Occluded Enteral Access Devices | Enteral Access Device | Gastric Feeding Tubes
-
Postgraduate Institute of Medical Education and...UnknownVascular Access DevicesIndia
Clinical Trials on the selection scheme of peripheral venous access devices
-
Kahramanmaras Sutcu Imam UniversityCompleted
-
University of SurreyCompletedCoronary Artery Disease | Osteoporosis | Osteopenia | Coronary Artery CalcificationUnited Kingdom
-
Near East University, TurkeyAl-Ahli Hospital, HebronActive, not recruitingDVT Prophylaxis | DVT - Deep Vein Thrombosis | Cardiac On-pump Surgery | DVT Prevention | On-pump Cardiac Surgery - Prevention - Intervention - Experimental Group - Control Group - Incidence - Complications | Nursing Care ProtocolCyprus
-
WithingsReykjavik University; Université Paris Cité; INSERM Neurodiderot UMR 1141Enrolling by invitation
-
Vidacare CorporationCompleted
-
Zhuan ZhangRecruitingIntraoperative Venous Congestion And Cognitive Dysfunction After Cardiac SurgeryChina
-
Zhuan ZhangRecruitingCardiac Surgery | Postoperative Delirium (POD) | Venous Congestion | IntraoperativeChina
-
Amplifi Vascular, Inc.RecruitingEnd Stage Kidney Disease (ESRD)United States
-
Cedars-Sinai Medical CenterTerminatedRotator Cuff TearsUnited States
-
Oman Medical Speciality BoardCompletedAsthma in Children | Shortness of Breath | Epinephrine Causing Adverse Effects in Therapeutic Use | Salbutamol Adverse ReactionOman